Your only treatment of mesothelioma news source! Click on each item to read full story.   Baron and Budd Draws Attention to New Chinese Mesothelioma Treatment Discovered Accidentally read story Non-Invasive Drug for TB Proves Effective in Easing Painful Effusion, Symptom of Late Stage Mesothelioma (PRWeb May 20, 2013) Read the full story at http://www.prweb.com/releases/2013/5/prweb10738887.htm   Best-Selling Book on Mesothelioma Chronicles Paul Kraus’ Unexpected Survival, 16 Years and Counting read story For Paul Kraus, the longest living mesothelioma survivor in the world, survival has never been easy. Even from birth, Kraus faced enormous challenges. He was the only person to be born in a Nazi forced labor camp during WWII and survive.   Aduro Announces Poster Presentations of Phase 2 Pancreatic Cancer and Phase 1B Mesothelioma Clinical Trials at ASCO read story Aduro BioTech, Inc. announces two poster presentations at the upcoming American Society of Clinical Oncology annual meeting in Chicago. Dr. Raffit Hassan, Head of the Solid Tumor Immunotherapy Section at the Laboratory of Molecular Biology at the National Cancer Institute, will present data from Aduro’s Phase 1B clinical trial in patients with malignant pleural mesothelioma .   New Mesothelioma Test May Revolutionize Diagnosis and Treatment According to Surviving Mesothelioma read story Surviving Mesothelioma reports that researchers from among the world’s top cancer centers say they have developed a test capable of recognizing the molecular “fingerprint” of malignant pleural mesothelioma. (PRWeb May 03, 2013) Read the full story at http://www.prweb.com/releases/2013/5/prweb10697838.htm   Verastem to Present at the 2013 ASCO Annual Meeting read story Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that members of the research and development team will present the clinical design for an ongoing study of VS-6063 and preclinical data on the dual PI3K/mTOR inhibitor VS-5584 at the American Society of Clinical Oncology Annual Meeting being held May 31 – June 4 ...   A New Target for Mesothelioma Treatment Shows Promise According to Surviving Mesothelioma read story Surviving Mesothelioma reports that a pair of Swiss researchers say they have identified a potential new target for mesothelioma therapy. (PRWeb April 30, 2013) Read the full story at http://www.prweb.com/releases/2013/4/prweb10683246.htm   Mesothelioma Victims Center Urges Victims Of Mesothelioma Who Worked In Manufacturing To Call Them For Instant Access ... read story The Mesothelioma Victims Center is urging diagnosed victims of mesothelioma, or their family members to call them for instant access to the nation's most experienced, and skilled mesothelioma lawyers, because mesothelioma compensation claims frequently exceed a million dollars for manufacturing, or industrial workers, and the law firms, or specific lawyers the group recommends to the victim, or ...   $150,000 Donation from Long-Time Supporter of Mesothelioma Research Helps Support The Pacific Meso Center's 2013 Agenda read story LOS ANGELES, May 2, 2013 /PRNewswire/ -- The Pacific Meso Center (PMC) is pleased to announce receipt of a generous donation from Roger G. Worthington of the Law Office of Worthington & Caron, P.C., a ...   Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference read story PHILADELPHIA and REHOVOT, Israel, May 22, 2013 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that Kenneth A. ...   Sokolove Law Addresses the Most Common Concerns from Mesothelioma Victims read story Today Trusted Mesothelioma Firm Provides Facts about Asbestos Exposure and Guidance on How to Take Legal Action (PRWeb May 06, 2013) Read the full story at http://www.prweb.com/releases/2013/5/prweb10697893.htm